Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV002285889 | SCV002575634 | uncertain significance | not provided | 2022-03-21 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV002285889 | SCV004275819 | likely benign | not provided | 2023-04-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004973401 | SCV005586642 | uncertain significance | Inborn genetic diseases | 2024-11-08 | criteria provided, single submitter | clinical testing | The c.12421C>G (p.L4141V) alteration is located in exon 25 (coding exon 24) of the FAT1 gene. This alteration results from a C to G substitution at nucleotide position 12421, causing the leucine (L) at amino acid position 4141 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |